143 related articles for article (PubMed ID: 32578129)
1. A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report.
Abolnezhadian F; Dehghani R; Dehnavi S; Khodadadi A; Shohan M
Immunol Res; 2020 Aug; 68(4):225-231. PubMed ID: 32578129
[TBL] [Abstract][Full Text] [Related]
2. MHC Class II Deficiency with Normal CD4+ T Cell Counts: A Case Report.
Abolnezhadian F; Saeedi-Boroujeni A; Iranparast S
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):594-600. PubMed ID: 30644704
[TBL] [Abstract][Full Text] [Related]
3. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Ouederni M; Vincent QB; Frange P; Touzot F; Scerra S; Bejaoui M; Bousfiha A; Levy Y; Lisowska-Grospierre B; Canioni D; Bruneau J; Debré M; Blanche S; Abel L; Casanova JL; Fischer A; Picard C
Blood; 2011 Nov; 118(19):5108-18. PubMed ID: 21908431
[TBL] [Abstract][Full Text] [Related]
5. MHC II deficient infant identified by newborn screening program for SCID.
Marcus N; Stauber T; Lev A; Simon AJ; Stein J; Broides A; Somekh I; Almashanu S; Somech R
Immunol Res; 2018 Aug; 66(4):537-542. PubMed ID: 30084052
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
9. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
Nekrep N; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
[TBL] [Abstract][Full Text] [Related]
11. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency.
Lennon-Duménil AM; Barbouche MR; Vedrenne J; Prod'Homme T; Béjaoui M; Ghariani S; Charron D; Fellous M; Dellagi K; Alcaïde-Loridan C
J Immunol; 2001 May; 166(9):5681-7. PubMed ID: 11313409
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II.
Damoiseaux M; Damoiseaux J; Pico-Knijnenburg I; van der Burg M; Bredius R; van Well G
Clin Immunol; 2022 Feb; 235():108932. PubMed ID: 35065305
[TBL] [Abstract][Full Text] [Related]
14. Novel Presentation of Major Histocompatibility Complex Class II Deficiency with Hemophagocytic Lymphohistiocytosis.
Alroqi FJ; Alhezam MA; Almojali AI; Barhoumi T; Althubaiti N; Alharbi Y; Al Balwi MA; Alrasheed A
J Clin Immunol; 2024 Mar; 44(3):73. PubMed ID: 38424321
[TBL] [Abstract][Full Text] [Related]
15. A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.
Cai YQ; Zhang H; Wang XZ; Xu C; Chao YQ; Shu Y; Tang LF
Open Forum Infect Dis; 2020 Aug; 7(8):ofaa314. PubMed ID: 32875002
[TBL] [Abstract][Full Text] [Related]
16. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
Prod'homme T; Dekel B; Barbieri G; Lisowska-Grospierre B; Katz R; Charron D; Alcaide-Loridan C; Pollack S
Immunogenetics; 2003 Nov; 55(8):530-9. PubMed ID: 14574520
[TBL] [Abstract][Full Text] [Related]
17. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile.
Al-Herz W; Alsmadi O; Melhem M; Recher M; Frugoni F; Notarangelo LD
J Clin Immunol; 2013 Apr; 33(3):513-9. PubMed ID: 23143406
[TBL] [Abstract][Full Text] [Related]
19. Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent.
Clarridge K; Leitenberg D; Loechelt B; Picard C; Keller M
J Clin Immunol; 2016 Jan; 36(1):4-5. PubMed ID: 26634365
[TBL] [Abstract][Full Text] [Related]
20. Novel variants in CIITA caused type II bare lymphocyte syndrome: A case report.
Zhang Y; Yokoyama Y; Qing Y; Han C; Zhu J; Yu T; Yin L; Yao R; Wang J
Asian Pac J Allergy Immunol; 2024 Mar; 42(1):81-85. PubMed ID: 33386785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
